136 related articles for article (PubMed ID: 21807018)
21. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
[TBL] [Abstract][Full Text] [Related]
22. Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA.
García-Pardo MP; Escobar-Valero C; Rodríguez-Arias M; Miñarro J; Aguilar MA
Behav Pharmacol; 2015 Aug; 26(5):411-7. PubMed ID: 25974188
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP.
Zarrindast MR; Nouri M; Ahmadi S
Brain Res; 2007 Aug; 1163():130-7. PubMed ID: 17631872
[TBL] [Abstract][Full Text] [Related]
24. The CB1 receptor as an important mediator of hedonic reward processing.
Friemel CM; Zimmer A; Schneider M
Neuropsychopharmacology; 2014 Sep; 39(10):2387-96. PubMed ID: 24718372
[TBL] [Abstract][Full Text] [Related]
25. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice.
Daza-Losada M; Ribeiro Do Couto B; Manzanedo C; Aguilar MA; Rodríguez-Arias M; Miñarro J
Neuropsychopharmacology; 2007 Aug; 32(8):1750-9. PubMed ID: 17299518
[TBL] [Abstract][Full Text] [Related]
26. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
[TBL] [Abstract][Full Text] [Related]
27. Effects of risperidone on the acquisition and reinstatement of the conditioned place preference induced by MDMA.
Roger-Sánchez C; Rodríguez-Arias M; Miñarro J; Aguilar MA
Brain Res Bull; 2013 Sep; 98():36-43. PubMed ID: 23892054
[TBL] [Abstract][Full Text] [Related]
28. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.
Pamplona FA; Prediger RD; Pandolfo P; Takahashi RN
Psychopharmacology (Berl); 2006 Nov; 188(4):641-9. PubMed ID: 16947018
[TBL] [Abstract][Full Text] [Related]
29. Involvement of 5-hydroxytryptamine 5-HT₃ serotonergic receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA.
Roger-Sánchez C; Rodríguez-Arias M; Miñarro J; Aguilar MA
Eur J Pharmacol; 2013 Aug; 714(1-3):132-41. PubMed ID: 23792143
[TBL] [Abstract][Full Text] [Related]
30. Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats.
Biala G; Budzynska B
Pharmacol Biochem Behav; 2008 Mar; 89(1):116-25. PubMed ID: 18178244
[TBL] [Abstract][Full Text] [Related]
31. Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice.
Vidal-Infer A; Roger-Sánchez C; Daza-Losada M; Aguilar MA; Miñarro J; Rodríguez-Arias M
PLoS One; 2012; 7(8):e43107. PubMed ID: 22916213
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
33. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
[TBL] [Abstract][Full Text] [Related]
34. Yohimbine reinstates extinguished 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats with prior exposure to chronic yohimbine.
Ball KT; Jarsocrak H; Hyacinthe J; Lambert J; Lockowitz J; Schrock J
Behav Brain Res; 2015 Nov; 294():1-6. PubMed ID: 26241170
[TBL] [Abstract][Full Text] [Related]
35. Effect of adolescent exposure to MDMA and cocaine on acquisition and reinstatement of morphine-induce CPP.
Daza-Losada M; Rodríguez-Arias M; Aguilar MA; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):701-9. PubMed ID: 18164530
[TBL] [Abstract][Full Text] [Related]
36. CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.
Vlachou S; Nomikos GG; Panagis G
Psychopharmacology (Berl); 2005 May; 179(2):498-508. PubMed ID: 15821959
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system.
Presley CS; Abidi AH; Moore BM
Anal Biochem; 2016 Apr; 498():8-28. PubMed ID: 26772161
[TBL] [Abstract][Full Text] [Related]
38. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
39. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
40. Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A.
Pozzi O; Misiano P; Clark GD; Visentin L
Pharmacology; 2003 Nov; 69(3):158-63. PubMed ID: 14512703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
